摘要
黄芪甲苷是中药黄芪的主要活性成分之一,研究证实具有抗氧化应激、抗炎、抗纤维化等作用,近年来研究发现黄芪甲苷与肾脏疾病的治疗关系密切,也与糖尿病肾病、慢性肾小球肾炎、高血压肾病、肾肿瘤、急性肾损伤等肾脏疾病具有相关性。本文简述黄芪甲苷与肾脏疾病的相关性。
AstragalosideⅣ(AS-Ⅳ)is one of the main active ingredients in the traditional Chinese medicine astragalus.Studies have shown that it has the effects of anti-oxidative stress,anti-inflammatory and anti-fibrosis.In recent years,studies have found that AS-Ⅳis closely related to the treatment of kidney disease and is also related to diabetic nephropathy,chronic glomerulonephritis,hypertensive nephropathy,renal tumors,acute kidney injury and other kidney diseases.This article briefly describes the relationship between AS-Ⅳand kidney disease.
作者
付兆鑫
刘中柱
郑奕楠
FU Zhaoxin;LIU Zhongzhu;ZHENG Yi’nan(the First Hospital affiliated to Jiamusi University,Jiamusi 154000,China;School of Clinical Medicine,Jiamusi University,Jiamusi 154007,China)
出处
《上海医药》
CAS
2022年第5期43-45,57,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
黄芪甲苷
肾脏疾病
糖尿病肾病
急性肾损伤
astragalosideⅣ
kidney disease
diabetic nephropathy
acute kidney injury
作者简介
付兆鑫,硕士研究生。主要研究方向为慢性肾脏病的发病机理、影响因素及治疗。E-mail:932009328@qq.com;通信作者:刘中柱,主任医师、教授、硕士研究生导师。研究方向:急慢性肾炎、肾病综合征、急慢性肾功能衰竭、泌尿系感染、各类继发性肾脏病的治疗、腹膜透析及血液净化治疗。E-mail:liuzhongzhu75@163.com。
